97 related articles for article (PubMed ID: 24646171)
1. A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.
Mazzucato M; Visonà Dalla Pozza L; Manea S; Minichiello C; Facchin P
Orphanet J Rare Dis; 2014 Mar; 9():37. PubMed ID: 24646171
[TBL] [Abstract][Full Text] [Related]
2. Reducing selection bias in case-control studies from rare disease registries.
Cole JA; Taylor JS; Hangartner TN; Weinreb NJ; Mistry PK; Khan A
Orphanet J Rare Dis; 2011 Sep; 6():61. PubMed ID: 21910867
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Healthcare Utilization in Pediatric Multiple Sclerosis and Neuromyelitis Optica: A Nationwide Population-Based Study in South Korea (2016-2020).
Woo H; Hwang J; Choi SA; Chae SA
Children (Basel); 2024 May; 11(5):. PubMed ID: 38790547
[TBL] [Abstract][Full Text] [Related]
4. Coding undiagnosed rare disease patients in health information systems: recommendations from the RD-CODE project.
Angin C; Mazzucato M; Weber S; Kirch K; Abdel Khalek W; Ali H; Maiella S; Olry A; Jannot AS; Rath A
Orphanet J Rare Dis; 2024 Jan; 19(1):28. PubMed ID: 38280999
[TBL] [Abstract][Full Text] [Related]
5. Estimating mortality in rare diseases using a population-based registry, 2002 through 2019.
Mazzucato M; Visonà Dalla Pozza L; Minichiello C; Toto E; Vianello A; Facchin P
Orphanet J Rare Dis; 2023 Nov; 18(1):362. PubMed ID: 37978388
[TBL] [Abstract][Full Text] [Related]
6. Hematological characteristics and hepatobiliary complications of hereditary spherocytosis in a tertiary care pediatric center: optimizing diagnosis and care through local and international networks.
Boaro MP; Reggiani G; D'Agnolo M; Munaretto V; Pozzebon F; Trapanese R; Martella M; Colombatti R
Front Pediatr; 2023; 11():1269645. PubMed ID: 37886235
[TBL] [Abstract][Full Text] [Related]
7. [Faster diagnosis of rare diseases with artificial intelligence-A precept of ethics, economy and quality of life].
Völkel L; Wagner AD
Inn Med (Heidelb); 2023 Nov; 64(11):1033-1040. PubMed ID: 37861723
[TBL] [Abstract][Full Text] [Related]
8. ORPHAcodes use for the coding of rare diseases: comparison of the accuracy and cross country comparability.
Mazzucato M; Pozza LVD; Facchin P; Angin C; Agius F; Cavero-Carbonell C; Corrochano V; Hanusova K; Kirch K; Lambert D; Lucano C; Maiella S; Panzaru M; Rusu C; Weber S; Zurriaga O; Zvolsky M; Rath A
Orphanet J Rare Dis; 2023 Sep; 18(1):267. PubMed ID: 37667299
[TBL] [Abstract][Full Text] [Related]
9. Frequency-based rare diagnoses as a novel and accessible approach for studying rare diseases in large datasets: a cross-sectional study.
Tröster TS; von Wyl V; Beeler PE; Dressel H
BMC Med Res Methodol; 2023 Jun; 23(1):143. PubMed ID: 37330464
[TBL] [Abstract][Full Text] [Related]
10. Design and Development of a Hospital-Based Coronary Artery Disease (CAD) Registry in Iran.
Garavand A; Rabiei R; Emami H
Biomed Res Int; 2023; 2023():3075489. PubMed ID: 36743517
[TBL] [Abstract][Full Text] [Related]
11. Real-world use of orphan medicinal products (OMPs) in rare disease (RD) patients: A population-based registry study.
Mazzucato M; Minichiello C; Vianello A; Visonà Dalla Pozza L; Toto E; Facchin P
Front Pharmacol; 2022; 13():940010. PubMed ID: 36249759
[No Abstract] [Full Text] [Related]
12. Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025.
Lech R; Chow G; Mann K; Mott P; Malmberg C; Forte L
Orphanet J Rare Dis; 2022 Oct; 17(1):371. PubMed ID: 36209128
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Burden of Rare Diseases: A Population-Based Study in Tuscany (Italy).
Baldacci S; Santoro M; Pierini A; Mezzasalma L; Gorini F; Coi A
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805212
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic registries for rare eye diseases.
Sharma M; Jain N; Singh V; Singla S; Aftab I
Indian J Ophthalmol; 2022 Jul; 70(7):2225-2230. PubMed ID: 35791100
[TBL] [Abstract][Full Text] [Related]
15. Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?
Postma MJ; Noone D; Rozenbaum MH; Carter JA; Botteman MF; Fenwick E; Garrison LP
Orphanet J Rare Dis; 2022 Apr; 17(1):157. PubMed ID: 35382853
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).
Félix TM; de Oliveira BM; Artifon M; Carvalho I; Bernardi FA; Schwartz IVD; Saute JA; Ferraz VEF; Acosta AX; Sorte NB; Alves D;
Orphanet J Rare Dis; 2022 Feb; 17(1):84. PubMed ID: 35209917
[TBL] [Abstract][Full Text] [Related]
17. The Financial Burden of Surgery for Congenital Malformations-The Austrian Perspective.
Gasparella P; Singer G; Kienesberger B; Arneitz C; Fülöp G; Castellani C; Till H; Schalamon J
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769683
[TBL] [Abstract][Full Text] [Related]
18. Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy.
Suppressa P; Pagella F; Lenato GM; Gaetani E; Serio I; Masala MS; Spinozzi G; Lizzio R; Matti E; De Silvestri A; Passali GC; Aguglia M; Crocione C; Sabbà C
Orphanet J Rare Dis; 2021 Sep; 16(1):378. PubMed ID: 34496900
[TBL] [Abstract][Full Text] [Related]
19. Separating the Wheat from the Chaff: The Use of Upstream Regulator Analysis to Identify True Differential Expression of Single Genes within Transcriptomic Datasets.
Hadwen J; Schock S; Farooq F; MacKenzie A; Plaza-Diaz J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208365
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with rare diseases: a population-based study in Tuscany (Italy).
Gorini F; Coi A; Mezzasalma L; Baldacci S; Pierini A; Santoro M
Orphanet J Rare Dis; 2021 Jun; 16(1):275. PubMed ID: 34127030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
